<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356900</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00060147</org_study_id>
    <nct_id>NCT02356900</nct_id>
  </id_info>
  <brief_title>Hyperbaric VO2max Study</brief_title>
  <official_title>Effects of High Intensity Interval Training in a Hyperoxic-hyperbaric Environment on Exercise Performance at Altitude</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to examine the effectiveness of training while in a hyperoxic-hyperbaric
      environment for exercise performance at altitude. Subjects will complete a short,
      high-intensity interval training (HIT) program inside the hyperbaric chamber.Before and after
      this training phase, all subjects will be tested for maximum aerobic capacity at a simulated
      high altitude of 15,000ft in a hypobaric chamber, as well as for molecular markers of
      mitochondrial oxidative capacity in a skeletal muscle biopsy.

      A group of individuals of similar characteristics completing this training program in a
      normoxic-normobaric environment will serve as a control.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of funding required to enroll target subject number
  </why_stopped>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Maximum Aerobic Capacity (VO2max) From Baseline to Post-training (&lt; 72 Hours )</measure>
    <time_frame>Baseline and &lt;72 hrs Post-training</time_frame>
    <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Ventilatory Threshold (VT) From Baseline to Post-training (&lt;72 Hours)</measure>
    <time_frame>Baseline and &lt;72 hrs Post-training</time_frame>
    <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mitochondrial Mass Change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Immunofluorescence microscopy using citrate synthase staining</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tfam Muscle Protein Content Change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Western analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pgc-1a Coactivator Muscle Protein Content Change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Western analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COX-I Gene Expression Change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Real-time PCR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle Phenotype Change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Immunofluorescence microscopy using citrate synthase staining</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Exercise Training</condition>
  <arm_group>
    <arm_group_label>Hyperoxic, Hyperbaric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normoxic, Normobaric</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperoxic hyperbaric interval exercise training</intervention_name>
    <description>Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.</description>
    <arm_group_label>Hyperoxic, Hyperbaric</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normoxic, normobaric, interval exercise training</intervention_name>
    <description>Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
    <arm_group_label>Normoxic, Normobaric</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>Used in Hyperoxic hyperbaric interval exercise training intervention</description>
    <arm_group_label>Hyperoxic, Hyperbaric</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy, recreationally active or sedentary individuals

        Exclusion Criteria:

          -  VO2max &lt; 35 ml/kg/min - male 30 ml/kg/min - female

          -  chronic cardiovascular or pulmonary diseases

          -  history of pneumothorax

          -  active smoker

          -  pregnant women

          -  non-english speaking

          -  not in full mental capacity

          -  blind

          -  sickle cell trait or disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2015</study_first_submitted>
  <study_first_submitted_qc>February 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2015</study_first_posted>
  <results_first_submitted>March 1, 2017</results_first_submitted>
  <results_first_submitted_qc>March 1, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 12, 2017</results_first_posted>
  <last_update_submitted>April 12, 2017</last_update_submitted>
  <last_update_submitted_qc>April 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>interval training</keyword>
  <keyword>hyperbaric oxygen</keyword>
  <keyword>VO2 max</keyword>
  <keyword>altitude</keyword>
  <keyword>exercise performance</keyword>
  <keyword>mitochondrial oxidative capacity</keyword>
  <keyword>mitochondrial biogenesis</keyword>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>25 participants were consented. 21 were randomized and completed the study, 1 was a screen failure, 1 withdrew after the initial biopsy and rash from bandage adhesive, 1 was withdrawn due to schedule noncompliance, and one was withdrawn after a syncopal episode during the initial biopsy.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Hyperoxic, Hyperbaric</title>
          <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
        </group>
        <group group_id="P2">
          <title>Normoxic, Normobaric</title>
          <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hyperoxic, Hyperbaric</title>
          <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
        </group>
        <group group_id="B2">
          <title>Normoxic, Normobaric</title>
          <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.0" spread="4.5"/>
                    <measurement group_id="B2" value="25.9" spread="4.8"/>
                    <measurement group_id="B3" value="25.4" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Maximum Aerobic Capacity (VO2max) From Baseline to Post-training (&lt; 72 Hours )</title>
        <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
        <time_frame>Baseline and &lt;72 hrs Post-training</time_frame>
        <population>Three participants in the Hyperoxic, Hyperbaric group and one participant in the Normoxic, Normobaric group were not included in the analysis due to experimental errors.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperoxic, Hyperbaric</title>
            <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
          </group>
          <group group_id="O2">
            <title>Normoxic, Normobaric</title>
            <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Maximum Aerobic Capacity (VO2max) From Baseline to Post-training (&lt; 72 Hours )</title>
          <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
          <population>Three participants in the Hyperoxic, Hyperbaric group and one participant in the Normoxic, Normobaric group were not included in the analysis due to experimental errors.</population>
          <units>mL/kg/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="5.0"/>
                    <measurement group_id="O2" value="4.2" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Ventilatory Threshold (VT) From Baseline to Post-training (&lt;72 Hours)</title>
        <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
        <time_frame>Baseline and &lt;72 hrs Post-training</time_frame>
        <population>Three participants in the Hyperoxic, Hyperbaric group and one participant in the Normoxic, Normobaric group were not included in the analysis due to experimental errors.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperoxic, Hyperbaric</title>
            <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
          </group>
          <group group_id="O2">
            <title>Normoxic, Normobaric</title>
            <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ventilatory Threshold (VT) From Baseline to Post-training (&lt;72 Hours)</title>
          <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
          <population>Three participants in the Hyperoxic, Hyperbaric group and one participant in the Normoxic, Normobaric group were not included in the analysis due to experimental errors.</population>
          <units>mL/kg/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="4.9"/>
                    <measurement group_id="O2" value="2.3" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mitochondrial Mass Change</title>
        <description>Immunofluorescence microscopy using citrate synthase staining</description>
        <time_frame>Baseline/24 hrs Post-training</time_frame>
        <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperoxic, Hyperbaric</title>
            <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
          </group>
          <group group_id="O2">
            <title>Normoxic, Normobaric</title>
            <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
          </group>
        </group_list>
        <measure>
          <title>Mitochondrial Mass Change</title>
          <description>Immunofluorescence microscopy using citrate synthase staining</description>
          <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tfam Muscle Protein Content Change</title>
        <description>Western analysis</description>
        <time_frame>Baseline/24 hrs Post-training</time_frame>
        <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperoxic, Hyperbaric</title>
            <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
          </group>
          <group group_id="O2">
            <title>Normoxic, Normobaric</title>
            <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
          </group>
        </group_list>
        <measure>
          <title>Tfam Muscle Protein Content Change</title>
          <description>Western analysis</description>
          <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pgc-1a Coactivator Muscle Protein Content Change</title>
        <description>Western analysis</description>
        <time_frame>Baseline/24 hrs Post-training</time_frame>
        <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperoxic, Hyperbaric</title>
            <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
          </group>
          <group group_id="O2">
            <title>Normoxic, Normobaric</title>
            <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
          </group>
        </group_list>
        <measure>
          <title>Pgc-1a Coactivator Muscle Protein Content Change</title>
          <description>Western analysis</description>
          <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>COX-I Gene Expression Change</title>
        <description>Real-time PCR</description>
        <time_frame>Baseline/24 hrs Post-training</time_frame>
        <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperoxic, Hyperbaric</title>
            <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
          </group>
          <group group_id="O2">
            <title>Normoxic, Normobaric</title>
            <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
          </group>
        </group_list>
        <measure>
          <title>COX-I Gene Expression Change</title>
          <description>Real-time PCR</description>
          <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Muscle Phenotype Change</title>
        <description>Immunofluorescence microscopy using citrate synthase staining</description>
        <time_frame>Baseline/24 hrs Post-training</time_frame>
        <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperoxic, Hyperbaric</title>
            <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
          </group>
          <group group_id="O2">
            <title>Normoxic, Normobaric</title>
            <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Phenotype Change</title>
          <description>Immunofluorescence microscopy using citrate synthase staining</description>
          <population>Muscle Biopsy samples were not analyzed due to funding issues.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Hyperoxic, Hyperbaric</title>
          <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.
Hyperoxic hyperbaric interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.
Oxygen: Used in Hyperoxic hyperbaric interval exercise training intervention</description>
        </group>
        <group group_id="E2">
          <title>Normoxic, Normobaric</title>
          <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.
Normoxic, normobaric, interval exercise training: Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <description>Dizziness resulting from hypoxemia due to exposure to high altitude, 15,000'.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard Moon, MD</name_or_title>
      <organization>Duke University Medical School</organization>
      <phone>919-684-6726</phone>
      <email>richard.moon@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

